STARHEALTHNSE29 April 2025

Star Health And Allied Insurance Company Limited has informed the Exchange about Investor Presentation

Star Health and Allied Insurance Company Limited

Date: April 29, 2025 Place: Chennai Ref: SHAI/B & S/SE/19/2025-26

To, The Manager, Listing Department, BSE Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400051, Mumbai – 400001, Maharashtra, India. Maharashtra, India. Scrip Code: 543412

To, The Manager, Listing Department, National Stock Exchange of India Limited, Exchange Plaza, 5th Floor, Plot C/1, G Block, Bandra-Kurla Complex,

Symbol: STARHEALTH

Dear Sir/ Madam,

Sub: Earnings Call Presentation- Q4 & FY2025

Further to our letter SHAI/B & S/SE/09/2025-26 dated April 16, 2025 regarding intimation of Q4 & FY2025 –Earnings Call, please find enclosed the presentation on performance of the Company to be made to the Investors and Analysts on Wednesday, April 30, 2025 at 8.30 A.M. IST for the quarter and year ended March 31, 2025.

The above information is also being hosted on the Company's website at www.starhealth.in.

This is for your kind information.

For Star Health and Allied Insurance Company Limited

Jayashree Sethuraman Company Secretary & Compliance Officer

Encl.: As above

INVESTOR PRESENTATION FY25

Executive Summary : FY25

Levers of Growth

Financial Performance

Customer Centricity

Agency

Banca

Corporate

Fresh Growth

Contribution to Fresh GWP

Fresh Growth

Contribution to Fresh GWP

Fresh Growth

Contribution to Fresh GWP

16%

61%

13%

15%

21%

7%

GWP (Cr) (without 1/n)

PAT (Cr) (IFRS)

Expense Ratio (IFRS)

Digital

Fresh Growth

Contribution to Fresh GWP

71%

17%

Combined Ratio (IFRS)

FY25

FY24

FY25

FY24

FY25

FY24

FY25

FY24

17553

15254

787

1103

30.4%

30.7%

101.1%

97.3%

Lives covered (Cr)

Renewal Ratio

NPS

Grievances/ 10k Policies

FY25

FY24

FY25

FY24

FY25

FY24

FY25

FY24

2.3

2.1

97%

98.4%

54

42

18

18

Above IFRS results are not mandated by sectoral regulator. IFRS financials are special purpose financial statements prepared with support from independent consultant (Big 4) GWP & Growth Numbers - without 1/n

Agenda

Our Strategy

Financial Performance

Key Pillars of Our Strategy

1

3

5

Retail Indemnity Expert

25%

Retail Fresh Growth

93%

GWP Contribution from Retail Policies

Digital First

70%

Digital Premium Collection

10Mn

App Downloads

Best-in- Class Claims Management

2

4

6

Unparallel Distribution Network

775k Agents 913 Branches

71 Banca Partners

Strong Operational Efficiency

2.21x

Solvency Ratio

15.1%

Opex/GWP

Customer Centricity

~1% GWP

Cost Efficient Processing

96%

Cashless < 3 Hours

54

18

Net Promoter Score

Grievances/10k Policies

GWP Numbers mentioned are on without 1/n basis Solvency & Opex/GWP - based on IGAAP

Key Performance Indicators

Particulars

Fiscal Year Ended March 31

(INR Crore, unless otherwise stated)

GWP (without 1/n)

Period-on-period growth of GWP (without 1/n)

Retail Health Renewal Premium Ratio (without 1/n on GWP)

Combined Ratio (without 1/n)

GWP (Reported basis)

Period-on-period growth of GWP (Reported basis)

Combined Ratio (Reported basis)

Investment Income

Investment Yield (Annualized)

Underwriting Profit/(Loss)

Profit/(Loss) after tax

Return on equity

Profit/(Loss) after tax - IFRS

Return on equity - IFRS

2023

12,952

13%

95%

95.3%

12,952

13%

95.3%

835

6.9%

205

619

12.4%

-

-

2024

15,254

18%

98.4%

96.7%

15,254

18%

96.7%

1083

7.7%

89

845

14.4%

1,103

15.2%

2025

17,553

15%

97%

100.2%

16,781

10%

101.1%

1279

7.8%

-378

646

9.7%

787

9.5%

Figures for the previous year / quarters and year to date have been re-grouped / re-arranged to conform to current year / current quarter and year to date presentation and regulatory requirements | Above IFRS results are not mandated by sectoral regulator. IFRS financials are special purpose financial statements prepared with support from independent consultant (Big 4)| Return on Equity = Profit After Tax/Average Net Worth. Numbers are basis 1/365 URR method.| With effect from Oct 01,2024, Long Term Products are accounted on 1/n basis, as mandated by IRDAI | GWP incl. 65Cr RI Inward.

Key Performance Indicators

Claims, Expense and Combined Ratios

Profit After Tax (PAT) - IFRS

(INR Crore)

95.3%

96.7%

101.1%

100.2%

101.1%

Expense Ratio

30.3%

30.2%

30.8%

29.9%

30.4%

Claims Ratio

65.0%

66.5%

70.3%

70.3%

70.7%

1,103

787

FY23 - IGAAP

FY24 - IGAAP

FY25 -IGAAP (with 1/n)

FY25 - IGAAP (without 1/n)

FY25 (IFRS)

FY24

FY25

Above IFRS results are not mandated by sectoral regulator. IFRS financials are special purpose financial statements prepared with support from independent consultant (Big 4) Note: All numbers are basis 1/365 URR method | 0.5% of PHC, telemedicine, OPD and wellness initiative included in FY25 Claims ratio

Leadership in Attractive Retail Segment

Retail Health Market Share

Gross Written Premium - Retail

Average Sum Insured – Retail Health

(INR Crore)

+17%

+15%

INR (Lacs)

34%

33%

33%

12114

14131

16255

+10%

10

11

+10%

14

16

FY23

FY24

FY25

FY23

FY24

FY25

Overall

Fresh

FY24

FY25

Market Share as per data published by GI Council GWP Numbers mentioned are on without 1/n basis

Ever- growing, Efficient Agency Network

Agency Force

In 000’s

Total Agency Force

Sponsored Agency Force

626

701

GWP Productivity / Agent

In Lacs INR

775

+7%

+8%

92

111

124

FY23

FY24

FY25

FY23

FY24

FY25

3.0

3.2

3.5

13% Overall GWP

Growth

GWP Numbers mentioned are on without 1/n basis

8% Agency Activation Fresh

Growth

7% Fresh NOP

Growth

Growth driven Banca & Alternate Partnerships

No. of Partnerships

Fresh GWP from Banca & Alternate Channels

In Cr INR

+13%

+24%

71

58

43

533

600

429

FY23

FY24

FY25

FY23

FY24

FY25

18% Overall GWP

Growth

22% RM Productivity

Growth

69% Benefit Contribution to

Fresh GWP - Banca

GWP Numbers mentioned are on without 1/n basis

Accelerating Digital Channel

No. of Tele callers

Retail Fresh GWP from D2C & Digital Partnerships

+40%

+36%

In Cr INR

+71%

+30%

2,033

687

1,449

1,062

309

401

FY23

FY24

FY25

FY23

FY24

FY25

51% Organic Traffic

Growth

55% Fresh NOP

Growth

97% Fresh NOPs

New to Insurance

GWP Numbers mentioned are on without 1/n basis

Digital-First

70% Digital premium collection

37% Claims auto- adjudicated

89% Policies Sourced Digitally

63% Policies Renewed w/o Human Intervention

10M Customer App downloads

1.2Mn+ Monthly Active User (Mar-25)

4.6 App Store Rating 4.4 Play Store Rating

400k+ Face Scans

Best in Class Claims Processing Capabilities

Claims Paid (Amount in Cr)

Cashless %

(Count)

ANH Share(%) Cashless Claims (Count)

7,781

8,914

58k Cr

10,353

73%

79%

83%

74%

78%

64%

14k+ Network Hospitals

FY23

FY24

FY25

FY23

FY24

FY25

FY23

FY24

FY25

Note: ANH refers to Agreed Network Hospitals with better negotiated package-based pricing. % Cashless includes Claims & wellness services

Customer Centric Wellness Initiatives

Preventive Health Checkups

Post Discharge Care

(in ‘000s)

+48%

Condition Management Programs – Diabetes, Hypertension, Cholesterol, Weight Management

(in ‘000s)

+430%

Condition Management Programs – Diabetes, Hypertension, Cholesterol, Weight Management

• Personalized services at the comfort of home

• Doctors and medical professionals right at doorstep.

260 58k Cr

385

Consultation with specialist doctors through The STAR Health App

58k Cr

FY24

FY25

59

FY24

310

FY25

6x Growth Wellness Enrolments from Q4FY24 to Q4FY25

156 Cities Home Health Care

+3% Increased NOP Retention

Customers who opted for PHC services

-17%

Lesser readmissions After Post-Discharge Care

Improving Customer Experience

Net Promoter Score

Grievances/10k policies

54

55

47

42

30

18

Overall NPS

Claims NPS

FY24

FY25

SAHI Industry

*

STAR

Based on 8L+ responses from 1.14 Cr triggers for NPS Survey - FY25 *Benchmarked 9MFY25 Data based on disclosures

Retail & Group Claims Ratio

Retail ICR(%)

Group ICR(%)

65.8%

69.2% 68.8%

89.8%

77.3%

FY24

FY25

FY24

FY25

Net incurred Loss ratio is defined as net incurred claims divided by net earned premium. All numbers are basis 1/365 URR method. 0.5% of PHC, telemedicine, OPD and wellness initiative included.

Agenda

Our Strategy

Financial Performance

Financial Performance

(As per IGAAP)

Claims, Expense and Combined Ratios

Opex / GWP Ratio

95.3%

Expense Ratio

30.3%

96.7%

30.2%

101.1%

30.8%

100.2%

29.9%

Claims Ratio

65.0%

66.5%

70.3%

70.3%

15.9%

15.7%

15.1%

FY23

FY24

FY25 (with 1/n)

FY25 (without 1/n)

FY23

FY24

FY25

Profit Before Tax INR Cr

Profit After Tax INR Cr

1,129

826

861

845

619

646

FY23

FY24

FY25

FY23

FY24

FY25

Figures for the previous year / quarters and year to date have been re-grouped / re-arranged to conform to current year / current quarter and year to date presentation and regulatory requirements.

Robust Investment Performance

(As per IGAAP)

Total Investments Assets

2.4x

INR billion

2.4x

2.5x

13,392

15,491

17,898

20,000

19,000

18,000

17,000

16,000

15,000

14,000

13,000

12,000

11,000

10,000

9,000

8,000

7,000

6,000

5,000

4,000

3,000

2,000

1,000

0

2.5

2.4

2.3

2.2

2.1

2.0

1.9

1.8

1.7

1.6

1.5

1.4

1.3

1.2

1.1

1.0

0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

0.0

Investment Income

INR Cr

835

1,083

1,279

FY23

FY24

FY25

FY23

FY24

FY25

Investment Leverage

Total AUM

Steady Returns...

(Annualized)

6.9%

7.7%

7.8%

FY23

FY24

FY25

76% G.Sec SDL, AAA, TREPs

Long-Term Funds

Short-Term Funds

Government Securities, State Development Loans, Corporate Bonds, Fixed Deposits, REITs, InvITs and ETFs

Bank FDs, Overnight Mutual Funds, CPs, CDs, T-Bills, CMBs, Short Maturity Bonds and Tri-Party REPOs (TREPs)

Figures for the previous year / quarters and year to date have been re-grouped / re-arranged to conform to current year / current quarter and year to date presentation and regulatory requirements.

IFRS to IGAAP Reconciliation

Above IFRS results are not mandated by sectoral regulator. IFRS financials are special purpose financial statements prepared with support from independent consultant (Big 4)

ParticularsFY24FY25Profit as per IGAAP845646Lease and Security Deposit-4-3Claims Risk Adjustment-8-57Share based Payments-17-14Deferred Acquisition Cost525370RI Long Term Commission-232-84Unrealised Gain / (Loss) on Investments & Provision - Expected Credit Loss (ECL)87-19Provision for Tax-93-52IFRS Impact258141Profit as per IFRS1103787 ESG

53

S&P Global CSA Score FY24

STAR Health Insurance becomes India's most sustainable Insurance company 2024 in the S&P Global Corporate Sustainability Assessment (CSA).

Environment

Social

Governance

• •

Achieved IGBC interiors platinum rating for the Corporate Office Procurement of appliances with a BEE rating of 3 & above Certificates provided by IT hardware vendors to verify carbon offsetting due to the purchase of energy-efficient devices E-waste being disposed through authorized third party Transitioned to e-claims for claim renewals Smart energy management systems & Energy audits

Launched 9 programs for chronic conditions and HER Health for women’s wellness, Mind and Body programs. Telemedicine: 45% growth, 1L+ consultations in 9+ languages, available 24/7 Home Healthcare: Expanded to 156 cities with trusted partners like Care24, Portea, and Athulya - 910 branches and 2,000+ customer touchpoints

• •

Achieved ISO 9001:2015 certification Policies updated - code of conduct, whistle blower ,anti fraud, anti-money laundering & Financial Inclusion policy Ensuring robust compliance and integrity practices

Disclaimer

The information contained in this presentation is provided by Star Health and Allied Insurance Company Limited (“SHAI or the Company”). The content of this presentation is for internal purposes only. Neither this presentation nor any part thereof shall be (i) used or relied upon by any other party or for any other purpose; (ii) copied, photocopied, duplicated or otherwise reproduced in any form or by any means; or (iii) re-circulated, redistributed, passed on, published in any media, website or otherwise disseminated, to any other person, in any form or manner, in part or as a whole, without the prior written consent of the Company.. This presentation does not allege to be a complete description of the market conditions or developments and is subject to change, without disclosure. Neither the Company nor any of its directors, officers, employees nor any other person assume any responsibility or liability for, the accuracy or completeness of, or any errors or omissions in, any information or opinions contained herein, and none of them accept any liability (in negligence, or otherwise) whatsoever for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection therewith. Any unauthorised use, disclosure or public dissemination of information contained herein is prohibited.

The statements contained in the presentation relates only as at the date of which they are made and it, should be understood that subsequent developments may affect the information contained herein.

By preparing this presentation, neither the Company nor its management undertakes any obligation to provide the recipient with access to any additional information or to update this presentation or to correct any inaccuracies in any such information which may become apparent. This document is for informational purposes and private circulation only and does not constitute or form part of a prospectus, a statement in lieu of a prospectus, an offering circular, offering memorandum, an advertisement, and should not be construed as an offer to sell or issue or the solicitation of an offer or an offer document to buy or acquire or sell securities of the Company or any of its subsidiaries or affiliates under the Companies Act, 2013, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, each as amended, or any applicable laws in India or as an inducement to enter into investment activity. No part of this document should be considered as a recommendation that any investor should subscribe to or purchase securities of the Company or any of its subsidiaries or affiliates and should not form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. This document is not financial, legal, tax, investment or other product advice

This presentation contains statements of future expectations and other forward-looking statements to enable investors to comprehend and take informed investment decisions. These statements include descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the consolidated results of operations and financial condition, and future events and plans of the Company.. These statements can be recognised by the use of words such as ‘anticipates’, ‘estimates’, ‘expects’, ‘projects’, ‘intends’, ‘plans’, ‘believes’ and words of similar substance in connection with any discussion of future performance. Such forward looking statements are not guarantees of future performance and involve risks and uncertainties and actual results, performances or events may differ from those in the forward-looking statements as a result of various factors, uncertainties and assumptions including but not limited to price fluctuations, actual demand, exchange rate fluctuations, competition, environmental risks, any change in legal, financial and regulatory frameworks, political risks and factors beyond the Company’s control

You are cautioned not to place undue reliance on these forward-looking statements, which are based on the current view of the management of the Company on future events. No assurance can be given that future events will occur, or that assumptions are correct. The Company does not assume any responsibility to amend, modify or revise any forward-looking statements, on the basis of any subsequent developments, information or events, or otherwise

Glossary

Particulars

FY

GWP

GEP

CAGR

Y-o-Y

URR

ANH

PA

SME

CoR

TAT

Financial Year

Gross Written Premium

Gross Earned Premium

Cumulative Annual Growth Rate

Year-on-Year

Unexpired Risk Reserve

Agreed Network Hospitals

Personal Accident

Small and Medium Enterprises

Combined Ratio

Turn Around Time

T H A N K Y O U

← All TranscriptsSTARHEALTH Stock Page →